Explore our library of archived lectures on hematological malignancies from The Science of Childhood Cancer hosted by the St. Jude Comprehensive Cancer Center. Please register for updates on upcoming virtual events.
Hematological malignancies lectures
-
RNA biology in MDS and modeling myelodysplasia
10/03/2024
Stephanie Halene, MD
Chief, Section of Hematology
Department of Internal Medicine and Yale Cancer Center
Yale University School of Medicine>br> -
Diagnosis of leukemia: from phenotype to genotype to artificial intelligence
09/12/2024
Torsten Haferlach, MD PhD
CEO
Munich Leukemia Laboratory -
Rising Stars of Cancer Research
08/15/2024
Rising Stars of Cancer Research
Decoding CAR T Cell Phenotype Using Combinatorial Signaling Motif Libraries and Machine Learning
Kyle Daniels, PhD
Stanford University School of Medicine
Targeting transcription factors to augment CAR T cell fitness
Evan Weber, PhD
University of Pennsylvania, Children’s Hospital of Philadelphia -
Recent results from translational and clinical studies in childhood acute lymphoblastic leukemia in the Princess Máxima Center
08/08/2024
Rob Pieters, MD PhD MSc
Chief Medical Officer
Princess Máxima Center for Pediatric Oncology -
Stem cell programs in high risk leukemias
03/28/2024
Kai Tan, PhD
Children’s Hospital of Philadelphia
University of Pennsylvania Perelman School of Medicine -
Understanding treatment resistance and relapse in ALL through single cell studies
03/21/2024
Kara Davis, DO
Stanford University -
Non-genetic mechanisms of clonal dominance in normal and malignant haematopoiesis
03/14/2024
Mark Dawson, MBBS (Hons), BMedSci, FRACP, FRCPA, PhD
University of Melbourne -
Beyond owl eyes - advances in pediatric and AYA Hodgkin lymphoma
02/29/2024
Sharon Castellino, MD, MSc
Emory University School of Medicine
Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta -
Understanding and targeting the non-coding regulatory genome
02/15/2024
Jian Xu, PhD
Center of Excellence for Leukemia Studies
Department of Pathology
St. Jude Children’s Research Hospital -
Novel venetoclax combinations for relapsed pediatric leukemia
08/17/2023
Rising Stars of Cancer Research
Seth Karol, MD
St. Jude Children's Research Hospital -
Hereditary Predisposition to Cancer: At the Tip of the Iceberg
05/25/2023
Kim E. Nichols, MD
St. Jude Children's Research Hospital -
New mechanistic insights into the development of pediatric myeloid tumors
05/18/2023
Jeffery M. Klco, MD, PhD
St. Jude Children's Research Hospital -
Emerging Therapies for Pediatric Leukemia
05/04/2023
Sarah K Tasian, MD
University of Pennsylvania School of Medicine
Children’s Hospital of Philadelphia -
HOX-high Leukemias in Childhood
03/30/2023
Kathrin M. Bernt, MD
The Children's Hospital of Philadelphia
University of Pennsylvania Abramson Cancer Center (NCI designated) -
Rising Stars of Cancer Research
03/23/2023
CAR T-cells for T-cell Malignancies: Proving and Improving
Maksim Mamonkin, PhD
Baylor College of Medicine
What Will it Take to Make CARTs Effective for Pediatric Brain Tumors?
Giedre Krenciute
St. Jude Children's Research Hospital -
Clonal Hematopoiesis and the Origins of Blood Cancers
02/16/2023
Benjamin Ebert, MD, PhD
Harvard Medical School
Dana-Farber Cancer Institute -
Targeting Bcl-2 Family Proteins in Leukemia
10/06/2022
Marina Konopleva, MD, PhD
Translational Blood Cancer Institute
University of Texas MD Anderson Cancer Center -
From Bedside to Bench and Back to Bedside: Travels in the Systems Biology of GVHD
09/22/2022
Leslie S. Kean, MD, PhD
Boston Children’s Hospital
Dana-Farber Cancer Institute
Harvard Medical School -
Unraveling the Heterogeneity of Acute Lymphoblastic Leukemia Through the Lens of Pharmacogenomics
05/05/2022
Jun J. Yang, PhD
St. Jude Children's Research Hospital -
Identify Novel Therapeutic Opportunities in Pediatric Cancers Using High-Resolution CRISPR Tiling Scans
04/28/2022
David Chen, PhD
City of Hope Cancer Center -
Clonal Evolution and Somatic Reversion in Genetic Predisposition to TP53-Mutated MDS
02/17/2022
Akiko Shimamura, MD, PhD
Harvard Medical School
Dana Farber/Boston Children’s Cancer and Blood Disorders Center -
What Will it Take To Cure Every Child with Acute Lymphoblastic Leukemia?
10/21/2021
Mignon Loh, MD
Benioff Children’s Hospital, UCSF, San Francisco, CA -
The Biology, Diagnosis, and Management of T-Cell Acute Lymphoblastic Leukemia and Lymphoma
09/16/2021
David T. Teachey, MD
The Children’s Hospital of Philadelphia
University of Pennsylvania Perelman School of Medicine -
Deconvoluting the Origins of Acute Leukemia
08/12/2021
Charles G. Mullighan, MBBS (Hons), MSc, MD St. Jude Children’s Research Hospital
-
Mechanisms of Leukemogenesis in Children with Down Syndrome
02/25/2021
John Crispino, PhD, MBA
St. Jude Children’s Research Hospital -
Chromatin Complexes as Therapeutic Opportunities in Cancer
02/11/2021
Scott Armstrong, MD, PhD
Dana-Farber Cancer Institute
Harvard Medical School -
3D Chromosomal Organization in Pediatric Leukemia: Impact for Drug Response and Disease Progression
10/01/2020
Iannis Aifantis, PhD
NYU Grossman School of Medicine -
Phase Separation in Gene Transcription: From the Nucleolus to Aberrant Transcription in Leukemia
09/03/2020
Richard W. Kriwacki, PhD
St. Jude Children's Research Hospital -
The Future of CAR T Cells for Hematologic Malignancies: Beyond Antigen Targeting Beyond Antigen Targeting
08/27/2020
Terry J. Fry, MD
University of Colorado School of Medicine
Children’s Hospital Colorado, Center for Cancer and Blood Disorders
Comprehensive Cancer Center
St. Jude is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children.
